Importance of Gleason score on 18F-choline PET/CT findings in patients with biochemical relapse of prostate cancer disease (PSA<1.0 ng/ml)

被引:1
|
作者
Hodolic, Marina
Cimitan, Marino
Fettich, Jure
机构
[1] Univ Med Ctr Ljubljana, Ljubljana, Slovenia
[2] Natl Canc Inst CRO, Aviano, Italy
关键词
D O I
10.1200/jco.2013.31.6_suppl.86
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
86
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Role of 18F-Choline PET/CT in restaging patients with prostate cancer with trigger PSA < 1 ng/ml
    Marzola, M. C.
    Chondrogiannis, S.
    Ferretti, A.
    Maffione, A. M.
    Rampin, L.
    Massaro, A.
    Grassetto, G.
    Rubello, D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S286 - S286
  • [2] Oligometastatic disease (OMD) in prostate cancer (PCa) detects by 18F-Choline (FCH) PET/CT in patients with PSA levels < 5 ng/mL
    Cuppari, L.
    Guttilla, A.
    Gardi, M.
    Agostini, A.
    Cervino, A.
    Reccia, P.
    Burei, M.
    Saladini, G.
    Hodolic, M.
    Evangelista, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S701 - S702
  • [3] 18F-choline PET/CT for distant metastases at early stage of prostate cancer recurrence (PSA< 2 ng/ml), when local salvage radiotherapy is intended
    Cimitan, M.
    Bagatin, E.
    Bortolus, R.
    Canzonieri, V.
    Morassut, S.
    Borsatti, E.
    Trovo, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S157 - S157
  • [4] 11C-choline PET/CT predicts survival in prostate cancer patients with PSA<1 NG/ml
    Giovacchini, Giampiero
    Guglielmo, Priscilla
    Mapelli, Paola
    Incerti, Elena
    Gajate, Ana Maria Samanes
    Giovannini, Elisabetta
    Riondato, Mattia
    Briganti, Alberto
    Gianolli, Luigi
    Ciarmiello, Andrea
    Picchio, Maria
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (04) : 921 - 929
  • [5] Therapy impact of 18F-PSMA PET/CT in biochemical recurrence of prostate cancer patients with PSA< 1 ng/ml postprostatectomy and 18F-Choline PET/CT negative
    Cozar Santiago, M.
    Garcia Garzon, J.
    Pastor Peiro, J.
    Bassa Massanas, P.
    Canoves Llombart, A.
    Aguilar Barrios, J.
    Sanz Llorens, R.
    Faus Rodrigo, V.
    Soler Lopez, M.
    Ferrer Rebolleda, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S266 - S266
  • [6] Standardization of acquisition protocol of 18F-choline PET/CT in prostate cancer patients with biochemical relapse
    Chondrogiannis, S.
    Marzola, M. C.
    Grassetto, G.
    Maffione, A. M.
    Secchiero, C.
    Rampin, L.
    Rubello, D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S393 - S393
  • [7] Early and Late Imaging of Choline PET/CT for the Detection of Prostatic Fossae Recurrences in Prostate Cancer with a Biochemical Failure (PSA&lt;2 ng/mL)
    Evangelista, L.
    Hodolic, M.
    Burei, M.
    Pizzirani, E.
    Ramondo, G.
    Saladini, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S337 - S337
  • [8] PET with 18F-Choline for evaluation of prostate cancer patients with biochemical relapse/persistence
    Perez Montero, H.
    Cabeza, M. A.
    Gomez, A.
    Guardado, S. G.
    Perez-Regadera, J. F.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S388 - S389
  • [9] 18F-Choline PET/CT and Prostate MRI for Staging Patients With Biochemical Relapse After Irradiation for Prostate Cancer
    Quero, Laurent
    Vercellino, Laetitia
    de Kerviler, Eric
    Mongiat-Artus, Pierre
    Culine, Stephane
    Merlet, Pascal
    Ravery, Vincent
    Meria, Paul
    Desgrandchamps, Francois
    Hennequin, Christophe
    [J]. CLINICAL NUCLEAR MEDICINE, 2015, 40 (11) : e492 - e495
  • [10] 18F-Choline PET/CT in Biochemical Recurrence of Prostate Cancer
    Riola-Parada, C.
    Lucas-Velazquez, B.
    Gomez-Caminero, F.
    Villanueva, J.
    Garcia-Talavera, P.
    Diaz, L.
    Penaherrera, A.
    Canadas Salazar, J.
    Tamayo, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S592 - S592